Taro Pharmaceutical Industries Ltd. is an Israel-based company, which develops, manufactures and markets market prescription (Rx) and over-the-counter (OTC) products in the United States, Canada and Israel. The Company focuses in semi-solids formulations such as creams and ointments and other dosage forms such as liquids, capsules and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The Company operates through Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company also focuses on providing branded and generic pharmaceuticals in the United Kingdom. Taro International sells active pharmaceutical ingredients and finished dosage form products in countries around the world.